ATE392214T1 - Impfstoff gegen geschlechtlich übertragene krankheiten - Google Patents

Impfstoff gegen geschlechtlich übertragene krankheiten

Info

Publication number: ATE392214T1
Authority: AT; Austria
Prior art keywords: vaccine against; sexually transmitted; transmitted diseases; against sexually; diseases
Prior art date: 1998-09-11

Application number

AT99969034T

Other languages

English (en)

Inventor

Moncef Slaoui

Pierre G Vandepapeliere

Original Assignee

Glaxosmithkline Biolog Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-11

Filing date

1999-09-08

Publication date

2008-05-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10838766&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE392214(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-09-08 Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa

2008-05-15 Application granted granted Critical

2008-05-15 Publication of ATE392214T1 publication Critical patent/ATE392214T1/de

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Virology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Biotechnology (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Bioinformatics & Cheminformatics (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

AT99969034T 1998-09-11 1999-09-08 Impfstoff gegen geschlechtlich übertragene krankheiten ATE392214T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB9819898A GB9819898D0 (en)	1998-09-11	1998-09-11	New vaccine and method of use

Publications (1)

Publication Number	Publication Date
ATE392214T1 true ATE392214T1 (de)	2008-05-15

Family

ID=10838766

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99969034T ATE392214T1 (de)	1998-09-11	1999-09-08	Impfstoff gegen geschlechtlich übertragene krankheiten

Country Status (28)

Country	Link
EP (1)	EP1109574B1 (de)
JP (1)	JP2002524532A (de)
KR (1)	KR100777896B1 (de)
CN (2)	CN1325311A (de)
AR (1)	AR021798A1 (de)
AT (1)	ATE392214T1 (de)
AU (1)	AU744989B2 (de)
BR (1)	BR9913630A (de)
CA (1)	CA2343399C (de)
CO (1)	CO5090882A1 (de)
CY (1)	CY1108147T1 (de)
CZ (1)	CZ302808B6 (de)
DE (1)	DE69938555T2 (de)
DK (1)	DK1109574T3 (de)
ES (1)	ES2304068T3 (de)
GB (1)	GB9819898D0 (de)
HU (1)	HUP0104297A3 (de)
IL (1)	IL141843A0 (de)
MY (1)	MY122216A (de)
NO (1)	NO329522B1 (de)
NZ (1)	NZ510425A (de)
PL (1)	PL199545B1 (de)
PT (1)	PT1109574E (de)
SI (1)	SI1109574T1 (de)
TR (1)	TR200100948T2 (de)
TW (1)	TWI225790B (de)
WO (1)	WO2000015255A1 (de)
ZA (1)	ZA200101987B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69935606T9 (de)	1998-10-16	2021-03-11	Glaxosmithkline Biologicals S.A.	Adjuvanzsysteme und impfstoffe
GB9921146D0 (en)	1999-09-07	1999-11-10	Smithkline Beecham Biolog	Novel composition
WO2006115509A2 (en)	2004-06-24	2006-11-02	Novartis Vaccines And Diagnostics Inc.	Small molecule immunopotentiators and assays for their detection
CA2630220C (en)	2005-11-22	2020-10-13	Doris Coit	Norovirus and sapovirus antigens
US20090317421A1 (en)	2006-01-18	2009-12-24	Dominique Missiakas	Compositions and methods related to staphylococcal bacterium proteins
CA2699513C (en)	2007-09-12	2018-03-13	Novartis Ag	Gas57 mutant antigens and gas57 antibodies
GB0818453D0 (en)	2008-10-08	2008-11-12	Novartis Ag	Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
WO2011008400A2 (en)	2009-06-16	2011-01-20	Novartis Ag	High-throughput complement-mediated antibody-dependent and opsonic bactericidal assays
WO2011026111A1 (en)	2009-08-31	2011-03-03	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Oral delivery of a vaccine to the large intestine to induce mucosal immunity
AU2011237393B2 (en)	2010-04-08	2015-01-22	University Of Pittsburgh - Of The Commonwealth System Of Higher Education	B-cell antigen presenting cell assay
KR20130121699A (ko)	2010-05-28	2013-11-06	테트리스 온라인, 인코포레이티드	상호작용 혼성 비동기 컴퓨터 게임 기반구조
CA2843854A1 (en)	2011-07-01	2013-01-10	The Regents Of The University Of California	Herpes virus vaccine and methods of use
US11071745B2 (en)	2014-07-07	2021-07-27	Elian Llc	Viral prophylaxis treatment methods and pre-exposure prophylaxis kits
JP7525976B2 (ja) *	2014-07-07	2024-07-31	エリアンリミテッドライアビリティカンパニー	ウイルス予防治療方法及び曝露前予防キット
BR112018017141A2 (pt)	2016-02-22	2019-01-02	Boehringer Ingelheim Vetmedica Gmbh	método para a imobilização de biomoléculas
WO2020086408A1 (en)	2018-10-26	2020-04-30	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	A high-yield perfusion-based transient gene expression bioprocess

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9105992D0 (en) *	1991-03-21	1991-05-08	Smithkline Beecham Biolog	Vaccine
ATE157882T1 (de) *	1993-03-23	1997-09-15	Smithkline Beecham Biolog	3-0-deazylierte monophosphoryl lipid a enthaltende impfstoff-zusammensetzungen
GB9326253D0 (en) *	1993-12-23	1994-02-23	Smithkline Beecham Biolog	Vaccines
GB9506863D0 (en) *	1995-04-03	1995-05-24	Smithkline Beecham Biolog	Vaccines

1998
- 1998-09-11 GB GB9819898A patent/GB9819898D0/en not_active Ceased
1999
- 1999-09-08 CN CN99813127A patent/CN1325311A/zh active Pending
- 1999-09-08 SI SI9931008T patent/SI1109574T1/sl unknown
- 1999-09-08 HU HU0104297A patent/HUP0104297A3/hu unknown
- 1999-09-08 CN CNA2007101469740A patent/CN101130070A/zh active Pending
- 1999-09-08 ES ES99969034T patent/ES2304068T3/es not_active Expired - Lifetime
- 1999-09-08 CZ CZ20010887A patent/CZ302808B6/cs not_active IP Right Cessation
- 1999-09-08 JP JP2000569839A patent/JP2002524532A/ja active Pending
- 1999-09-08 AU AU59752/99A patent/AU744989B2/en not_active Ceased
- 1999-09-08 KR KR1020017003161A patent/KR100777896B1/ko not_active Expired - Fee Related
- 1999-09-08 PL PL346651A patent/PL199545B1/pl not_active IP Right Cessation
- 1999-09-08 AT AT99969034T patent/ATE392214T1/de active
- 1999-09-08 BR BR9913630A patent/BR9913630A/pt not_active Application Discontinuation
- 1999-09-08 EP EP99969034A patent/EP1109574B1/de not_active Expired - Lifetime
- 1999-09-08 CA CA 2343399 patent/CA2343399C/en not_active Expired - Fee Related
- 1999-09-08 NZ NZ51042599A patent/NZ510425A/xx not_active IP Right Cessation
- 1999-09-08 PT PT99969034T patent/PT1109574E/pt unknown
- 1999-09-08 IL IL14184399A patent/IL141843A0/xx not_active IP Right Cessation
- 1999-09-08 WO PCT/EP1999/006623 patent/WO2000015255A1/en not_active Ceased
- 1999-09-08 DE DE1999638555 patent/DE69938555T2/de not_active Expired - Lifetime
- 1999-09-08 DK DK99969034T patent/DK1109574T3/da active
- 1999-09-08 TR TR200100948T patent/TR200100948T2/xx unknown
- 1999-09-09 AR ARP990104534 patent/AR021798A1/es unknown
- 1999-09-09 MY MYPI99003916A patent/MY122216A/en unknown
- 1999-09-10 CO CO99057608A patent/CO5090882A1/es unknown
- 1999-09-14 TW TW88115828A patent/TWI225790B/zh not_active IP Right Cessation
2001
- 2001-03-08 NO NO20011193A patent/NO329522B1/no not_active IP Right Cessation
- 2001-03-09 ZA ZA200101987A patent/ZA200101987B/en unknown
2008
- 2008-06-18 CY CY081100643T patent/CY1108147T1/el unknown

Also Published As

Publication number	Publication date
HK1037978A1 (en)	2002-03-01
CZ2001887A3 (cs)	2001-10-17
EP1109574B1 (de)	2008-04-16
HUP0104297A3 (en)	2004-10-28
MY122216A (en)	2006-03-31
PL346651A1 (en)	2002-02-25
CA2343399A1 (en)	2000-03-23
TWI225790B (en)	2005-01-01
DK1109574T3 (da)	2008-06-30
DE69938555D1 (de)	2008-05-29
BR9913630A (pt)	2001-05-22
NZ510425A (en)	2003-04-29
PL199545B1 (pl)	2008-09-30
GB9819898D0 (en)	1998-11-04
IL141843A0 (en)	2002-03-10
CZ302808B6 (cs)	2011-11-23
ES2304068T3 (es)	2008-09-01
PT1109574E (pt)	2008-06-12
AU744989B2 (en)	2002-03-07
KR100777896B1 (ko)	2007-11-27
KR20010075049A (ko)	2001-08-09
NO329522B1 (no)	2010-11-01
EP1109574A1 (de)	2001-06-27
NO20011193L (no)	2001-05-09
AU5975299A (en)	2000-04-03
CA2343399C (en)	2010-08-03
ZA200101987B (en)	2002-05-09
DE69938555T2 (de)	2009-06-10
TR200100948T2 (tr)	2001-07-23
SI1109574T1 (sl)	2008-08-31
JP2002524532A (ja)	2002-08-06
WO2000015255A1 (en)	2000-03-23
CY1108147T1 (el)	2014-02-12
AR021798A1 (es)	2002-08-07
CN1325311A (zh)	2001-12-05
CN101130070A (zh)	2008-02-27
HUP0104297A2 (hu)	2002-03-28
CO5090882A1 (es)	2001-10-30
NO20011193D0 (no)	2001-03-08

Legal Events

Date

Code

Title

Description

2008-10-15

UEP

Publication of translation of european patent specification

Ref document number: 1109574

Country of ref document: EP

Publication	Publication Date	Title
NO20014325L (no)	2001-11-14	Vaksine
ATE413188T1 (de)	2008-11-15	Menschliche papillomavirus impfstoff- formulierungen
NO20006191D0 (no)	2000-12-06	Vaksine
NO20031483D0 (no)	2003-04-01	Vaksine
DK1637127T3 (da)	2014-08-04	Terapeutisk mikroskum
NO20003302L (no)	2000-08-18	Vaksine
NO20024172L (no)	2002-11-01	Vaksine
DE60019672D1 (de)	2005-06-02	Flacher Fussschalter
DE60002650D1 (de)	2003-06-18	Öladjuvierter Impfstoff
NO20020763L (no)	2002-04-16	Vaksine
ATE392214T1 (de)	2008-05-15	Impfstoff gegen geschlechtlich übertragene krankheiten
DE60008906D1 (de)	2004-04-15	Medizinische zange
DE60032510D1 (de)	2007-02-01	Kondom
NO20005599D0 (no)	2000-11-06	Vaksine
EP1105154A4 (de)	2005-03-09	Impfstoffe gegen bakterielle superantigene
ATE295687T1 (de)	2005-06-15	Gegen pflanzenkrankheiten verwendbare pseudomycine
ATE431415T1 (de)	2009-05-15	Hiv impfstoff
SE0003798D0 (sv)	2000-10-20	Specialkondom
SE0102635L (sv)	2003-02-01	Kondom
SE0100245D0 (sv)	2001-01-29	Kondom
ITCA20000013A0 (it)	2000-06-16	Cuscino ortopedico universale
SK2649U (sk)	2000-09-12	Prezervatív so stimulačným účinkom
FI4458U1 (fi)	2000-06-02	Savusauna
SE0102824D0 (sv)	2001-08-24	Preventivmedel
HU0002033D0 (en)	2000-08-28	Vaccine against diseases causing of chicken parvovirus